FULCRUM THERAPEUTICS, INC. (FULC) Return on equity 2020–2025
FULCRUM THERAPEUTICS, INC. (FULC) return on equity by fiscal year — reported net income divided by year-end shareholders’ equity.
-21.5%FY2025 · since FY2020: -74.4% → -21.5%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -21.5% | -17.5 pp |
| FY2024 | -4.0% | +37.4 pp |
| FY2023 | -41.4% | +13.8 pp |
| FY2022 | -55.2% | -17.0 pp |
| FY2021 | -38.2% | +36.2 pp |
| FY2020 | -74.4% | — |
ROE = reported net income ÷ reported year-end shareholders’ equity for the same fiscal year. Heavy buybacks shrink equity and can push ROE very high (or negative-equity years drop out).
Source: SEC XBRL filings · For reference only · Not investment advice
More FULC financial trends
FULC RevenueFULC Net incomeFULC Net marginFULC Gross profitFULC Gross marginFULC Operating incomeFULC Operating marginFULC Operating cash flowFULC Free cash flowFULC Capital expendituresFULC Stock buybacksFULC Dividends paidFULC Total assetsFULC Total liabilitiesFULC Shareholders’ equityFULC overview →